GSEA分析确定了冠状动脉微循环障碍中的潜在药物点及其相互作用网络
Nan Tang1, Qiang Zhou1, Shuang Liu1
1Department of Cardiology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, China.
SLAS technology
|June 1, 2024
概括
冠状动脉微循环功能障碍 (CMD) 需要个性化治疗. 基因组丰富分析 (GSEA) 确定了潜在的药物标和网络,比传统方法更准确,以更好地干预心血管疾病.
科学领域:
- 生物信息学是一种生物信息学.
- 心血管疾病研究研究
- 基因组学就是基因组学.
背景情况:
- 冠状动脉微循环功能障碍 (CMD) 是心血管疾病的主要原因,但目前的治疗方法缺乏特异性和个性化方法.
- 现有的干预措施侧重于症状管理,具有可变的长期疗效.
- 由于CMD的复杂性,需要标准化的诊断和治疗计划,以获得最佳的结果.
研究的目的:
- 探索潜在的药物点和交互网络,以利用生物信息学来个性化治疗CMD.
- 应用基因组丰富分析 (GSEA) 识别丰富途径并计算与CMD相关的丰富分数.
- 与其他方法相比,评估GSEA在识别潜在药物点方面的有效性.
主要方法:
- 利用Coremine,GeneCards和DrugBank数据库收集CMD的基因数据.
- 预处理基因表达数据并应用GSEA以确定相关途径和丰富分数.
- 使用自身相关性提取了蛋白质序列特征,并将GSEA与基因调节网络 (GRN) 和随机森林 (RF) 方法进行了比较.
主要成果:
- GSEA确定了潜在的药物点和相互作用网络,这些网络对CMD至关重要.
- 实验分析表明GSEA在精度,ROC曲线,相关性和目标识别方面的有效性.
- 与GRN和RF方法相比,GSEA显示了0.11的平均精度改善.
结论:
- 在CMD中,GSEA为识别和探索潜在的药物点及其相互作用网络提供了有价值的工具.
- 这种方法为开发个性化干预和改善CMD患者治疗质量提供了新的见解.
- 这些发现支持使用GSEA来推进心血管疾病的精准医学.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
554
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
1.3K
相关概念视频
01:11Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
01:26Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
01:28Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699